User Access Funding for Projects at Italian Nodes


Published March 27, 2025

We are delighted to announce that the MultiModal Molecular Imaging Italian Node and the Advanced Light Microscopy (ALM) Italian Node are launching a call for user access funding under the SEELIFE project (PNRR – NextGenerationEU - Project “StrEngthEning the ItaLIan InFrastructure of Euro-bioimaging – SEE LIFE” IR0000023, CUP 24C660A8, financed by the Italian Ministry of University and Research). This initiative aims to foster international collaboration by providing free-of-charge access to cutting-edge imaging technologies for biomedical, pharmaceutical, and life science research. 

The total available budget is €280,600 covering user access to eight facilities included in the Nodes. This call supports both national and trans-national access, for both academic and industrial users.

Applications must successfully pass both scientific and technical evaluations according to the Euro-BioImaging user access procedure and receive final approval by the SEELIFE Technical and Scientific Committee.

The funding will be awarded on a first come, first served basis, so apply early! 

More information

Application deadline: September 15, 2025

SEELIfe - Italian User Access Fund

More news from Euro-BioImaging

Group photo at the EU-Australian Health Research Infrastructure Symposium in Prato, 2025.

September 24, 2025

Successful Australian & European Health Research Infrastructures symposium

From September 16-19, 2025, representatives of European and Australian Health Research Infrastructures gathered at the Monash University Prato Centre in Prato, Italy. The Euro-BioImaging…

September 23, 2025

New European strategy on Research & Technology Infrastructures

The European Commission has published its new Strategy on Research & Technology Infrastructures that aims to “make the EU the best place in the…

Representative MRI images of livers.

September 16, 2025

Spotlight - Johnson Lok – Advanced Microbiome Therapeutics (AMT)

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent liver disease globally, yet no therapies…